OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

9473	Companies
185423	Keywords
117773	Articles
99292	Press releases

Home
Companies
OXURION

BRIEF

published on 09/01/2025 at 18:05, 3 months 3 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Atlas Special Opportunities Oxurion Participation Thresholds
PRESS RELEASE

published on 09/01/2025 at 18:00, 3 months 3 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications under Belgian legislation from Atlas Special Opportunities II, LLC regarding changes in voting securities holdings

Oxurion NV Belgian Legislation Transparency Notifications Voting Securities Atlas Special Opportunities II LLC
BRIEF

published on 08/07/2025 at 18:05, 3 months 28 days ago

Oxurion receives transparency notifications from UBS Group AG

Investors Actions Transparency UBS Group AG Oxurion
PRESS RELEASE

published on 08/07/2025 at 18:00, 3 months 28 days ago

Oxurion Receives Transparency Notifications from UBS Group AG
Oxurion NV received transparency notifications from UBS Group AG regarding share holdings, in compliance with Belgian Transparency legislation. The company is a biopharmaceutical group focusing on therapeutic innovation and clinical research technologies

Clinical Research Biopharmaceutical UBS Group AG Oxurion NV Transparency Notifications
BRIEF

published on 08/06/2025 at 18:05, 3 months 29 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 08/06/2025 at 18:00, 3 months 29 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding changes in shareholding from Atlas Special Opportunities II, LLC as per Belgian Transparency legislation. Company combines therapeutic innovation with technology for new treatments

Clinical Research Shareholding Changes Oxurion NV Therapeutic Innovation Transparency Notifications
BRIEF

published on 08/04/2025 at 18:05, 4 months ago

Oxurion Secures EUR 30M for Diversification into Digital Assets

Funding Investment Cryptocurrencies Biopharmaceuticals Oxurion
PRESS RELEASE

published on 08/04/2025 at 18:00, 4 months ago

Oxurion announces it obtained an improved indicative EUR 30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets
Oxurion NV receives €30 million financing offer from Atlas Special Opportunities for investment in digital assets. Company remains confident in closing the transaction by August 2025

Investment Digital Assets Oxurion NV Financing Offer August 2025
BRIEF

published on 08/04/2025 at 08:35, 4 months 1 day ago

Oxurion completes acquisition of 72% of Axiodis CRO

Acquisition External Growth Clinical Data Oxurion Axiodis CRO
PRESS RELEASE

published on 08/04/2025 at 08:30, 4 months 1 day ago

Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform
Oxurion completes the acquisition of 72% stake in Axiodis CRO, paving the way for an integrated platform focused on clinical data. Intensifies discussions with strategic targets in France and Europe

Acquisition Europe Intégration Clinical Data Oxurion

Accesswire

Published on 12/05/2025 at 02:35, 7 hours 40 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 7 hours 45 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours 15 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 10 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 15 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 09:40, 35 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 45 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 10 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 15 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 1 hour 15 minutes ago

SPECTRIS PLC - Removal

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 30 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours 15 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 30 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 31 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE